Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The multiple phenotypes of allosteric receptor mutants

J L Galzi1, S J Edelstein, J Changeux

  • 1Centre National de la Recherche Scientifique Unité de Recherche Associée D1284, Neurobiologie Moléculaire, Institut Pasteur, Paris, France.

Proceedings of the National Academy of Sciences of the United States of America
|March 5, 1996
PubMed
Summary

Point mutations in neurotransmitter receptors can alter binding sites, ion channel activity, or conformational changes, leading to diverse functional phenotypes. This allosteric model explains complex receptor behaviors and predicts distinct mutation categories.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states.

The Journal of biological chemistry·2001
Same author

Neurotoxicity of channel mutations in heterologously expressed alpha7-nicotinic acetylcholine receptors.

The European journal of neuroscience·2001
Same author

Allosteric mechanisms in normal and pathological nicotinic acetylcholine receptors.

Current opinion in neurobiology·2001
Same author

Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1 alpha requires interaction with cell surface heparan sulfate proteoglycans.

The Journal of biological chemistry·2001
Same author

Desensitization of neuronal nicotinic acetylcholine receptors conferred by N-terminal segments of the beta 2 subunit.

Biochemistry·2001
Same author

Structural differences in the two agonist binding sites of the Torpedo nicotinic acetylcholine receptor revealed by time-resolved fluorescence spectroscopy.

Biochemistry·2000

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biophysics

Background:

  • Channel-linked neurotransmitter receptors are crucial for signal transduction, mediating communication between cells.
  • These receptors are heterooligomers composed of homologous subunits, existing in multiple conformations with distinct properties.
  • Mutations in receptor subunits can lead to diverse functional alterations and complex phenotypes.

Purpose of the Study:

  • To interpret the diversity of functional properties and phenotypes arising from point mutations in neurotransmitter receptor subunits.
  • To propose and analyze an allosteric model explaining these complex receptor behaviors.
  • To categorize mutation-induced phenotypes based on their effects on receptor properties.

Main Methods:

  • Development and application of an allosteric model incorporating multiple discrete conformational states.

Related Experiment Videos

  • Quantitative analysis of nicotinic acetylcholine and glycine receptor mutants.
  • Classification of mutation effects into K (binding site properties), gamma (channel activity), and L (isomerization constants) phenotypes.

    • Main Results:

    • The allosteric model successfully explains complex phenotypes observed in receptor mutants.
    • Point mutations can be categorized into three main types affecting binding sites, channel activity, or conformational transitions.
    • Analogies among different receptor phenotypes were identified and discussed.

    Conclusions:

    • An allosteric model provides a framework for understanding how mutations impact neurotransmitter receptor function.
    • The K, gamma, and L phenotype categories offer a systematic way to classify mutation effects.
    • This model aids in interpreting the molecular basis of diverse receptor-associated biological activities and diseases.